Elisa Gualdani1, Graziano Di Cianni2, Marta Seghieri3, Paolo Francesconi1, Giuseppe Seghieri4. 1. Epidemiology Unit, Regional Health Agency of Tuscany, Via Pietro Dazzi 1, 50141, Florence, Italy. 2. Diabetes and Metabolic Diseases Unit, Health Local Unit North-West Tuscany, Livorno, Italy. 3. Diabetes and Metabolic Diseases Unit, "San Giovanni Di Dio" Hospital, Florence, Italy. 4. Epidemiology Unit, Regional Health Agency of Tuscany, Via Pietro Dazzi 1, 50141, Florence, Italy. gseghier@tin.it.
Abstract
AIMS: To examine risk of adverse pregnancy outcomes, mothers' characteristics and incidence rate over time of pregestational type 1 (T1D), type 2 (T2D) or gestational diabetes (GDM). METHODS: The study included all singleton live births born from women aged 15-45 year, in Tuscany, Italy from 2010 to 2018. Pregnancy outcomes were retrieved by certificates of care at delivery compiled by midwives. Pregestational diabetes and GDM were identified by regional administrative databases. Time course of pregestational diabetes and GDM across last decade was assessed by Poisson analysis. Logistic regression analysis was used to calculate adjusted odds ratios (OR; 95% CI) for maternal characteristics or neonatal outcomes. RESULTS: Among 206,917 singleton live births, GDM was diagnosed in 21,613 pregnancies (10.46%) and pregestational diabetes in 979, being T2D more prevalent than T1D (606; 0.29% vs. 373; 0.18%). Pregestational T2D incidence progressively decreased over last decade, T1D remained stable while GDM progressively rose. Pre-pregnancy obesity, preterm deliveries or cesarean sections were common characteristics of pregestational diabetes and GDM. Risk of neonatal distress and neonatal malformations was higher in pregestational T1D. Risk of prior spontaneous abortions was higher in GDM and in pregestational T2D (OR: 4.19; 3.30-5.33), mostly treated with metformin. Risk of neonatal macrosomia was increased only in pregestational diabetes. CONCLUSIONS: In our population, pregestational T2D was more prevalent than T1D. Neonatal complications were mostly associated with pregestational T1D. Increased risk of previous spontaneous abortions was the hallmark of pregestational T2D. GDM, even if sharing adverse outcomes with pregestational T2D, was unrelated to rise in risk of neonatal macrosomia.
AIMS: To examine risk of adverse pregnancy outcomes, mothers' characteristics and incidence rate over time of pregestational type 1 (T1D), type 2 (T2D) or gestational diabetes (GDM). METHODS: The study included all singleton live births born from women aged 15-45 year, in Tuscany, Italy from 2010 to 2018. Pregnancy outcomes were retrieved by certificates of care at delivery compiled by midwives. Pregestational diabetes and GDM were identified by regional administrative databases. Time course of pregestational diabetes and GDM across last decade was assessed by Poisson analysis. Logistic regression analysis was used to calculate adjusted odds ratios (OR; 95% CI) for maternal characteristics or neonatal outcomes. RESULTS: Among 206,917 singleton live births, GDM was diagnosed in 21,613 pregnancies (10.46%) and pregestational diabetes in 979, being T2D more prevalent than T1D (606; 0.29% vs. 373; 0.18%). Pregestational T2D incidence progressively decreased over last decade, T1D remained stable while GDM progressively rose. Pre-pregnancy obesity, preterm deliveries or cesarean sections were common characteristics of pregestational diabetes and GDM. Risk of neonatal distress and neonatal malformations was higher in pregestational T1D. Risk of prior spontaneous abortions was higher in GDM and in pregestational T2D (OR: 4.19; 3.30-5.33), mostly treated with metformin. Risk of neonatal macrosomia was increased only in pregestational diabetes. CONCLUSIONS: In our population, pregestational T2D was more prevalent than T1D. Neonatal complications were mostly associated with pregestational T1D. Increased risk of previous spontaneous abortions was the hallmark of pregestational T2D. GDM, even if sharing adverse outcomes with pregestational T2D, was unrelated to rise in risk of neonatal macrosomia.
Entities:
Keywords:
Adverse neonatal outcomes; Gestational diabetes; Maternal characteristics; Pregestational type 1 diabetes; Pregestational type 2 diabetes; Time trends
Authors: Yuxiao Wu; Buyun Liu; Yangbo Sun; Yang Du; Mark K Santillan; Donna A Santillan; Linda G Snetselaar; Wei Bao Journal: Diabetes Care Date: 2020-10-21 Impact factor: 19.112
Authors: Sharon T Mackin; Scott M Nelson; Joannes J Kerssens; Rachael Wood; Sarah Wild; Helen M Colhoun; Graham P Leese; Sam Philip; Robert S Lindsay Journal: Diabetologia Date: 2018-01-11 Impact factor: 10.122
Authors: Sarit Helman; Tamarra M James-Todd; Zifan Wang; Andrea Bellavia; Jennifer A Wyckoff; Shanti Serdy; Elizabeth Halprin; Karen O'Brien; Tamara Takoudes; Munish Gupta; Thomas F McElrath; Florence M Brown Journal: J Perinatol Date: 2020-06-02 Impact factor: 2.521
Authors: Stefan Dugalic; Milos Petronijevic; Brankica Vasiljevic; Jovana Todorovic; Dejana Stanisavljevic; Aleksandra Jotic; Ljiljana Lukic; Tanja Milicic; Nebojsa Lalić; Katarina Lalic; Milica Stoiljkovic; Zorica Terzic-Supic; Tamara Stanisavljevic; Aleksandar Stefanovic; Katarina Stefanovic; Svetlana Vrzic-Petronijevic; Maja Macura; Igor Pantic; Pavle Piperac; Marija Jovanovic; Radmila Cerovic; Sinisa Djurasevic; Sandra Babic; Sonja Perkovic-Kepeci; Miroslava Gojnic Journal: Int J Environ Res Public Health Date: 2022-05-27 Impact factor: 4.614
Authors: Nompumelelo Malaza; Matladi Masete; Sumaiya Adam; Stephanie Dias; Thembeka Nyawo; Carmen Pheiffer Journal: Int J Environ Res Public Health Date: 2022-08-31 Impact factor: 4.614
Authors: Miroslava Gojnic; Jovana Todorovic; Dejana Stanisavljevic; Aleksandra Jotic; Ljiljana Lukic; Tanja Milicic; Nebojsa Lalic; Katarina Lalic; Milica Stoiljkovic; Tamara Stanisavljevic; Aleksandar Stefanovic; Katarina Stefanovic; Svetlana Vrzic-Petronijevic; Milos Petronijevic; Zorica Terzic-Supic; Maja Macura; Milan Perovic; Sandra Babic; Pavle Piperac; Marija Jovanovic; Bijana Parapid; Krisitna Doklestic; Radmila Cerovic; Sinisa Djurasevic; Stefan Dugalic Journal: Int J Environ Res Public Health Date: 2022-03-20 Impact factor: 3.390